11. McGlave P, Beatty P, Ash R, Hows JM. Therapy for chronic 
myelogenous leukemia with unrelated donor bone marrow 
transplantation: results in 102 cases. Blood 1990; 75:1728-1732. 
12. Beatty PG, Anasetti C. Marrow transplantation from donors 
other than HLA identical siblings. Hematology Oncology Clinics of 
North America 1990; 4:677-686. 
13. Ozer H, et al . Prolonged administration of subcutaneous 
alpha interferon induces major cytogenetic remissions in 
untreated Philadelphia chromosome positive (Ph+) chronic 
myelogenous leukemia (CML) . Proc Am Soc Clin Oncol 1990; 9:783. 
14. Silver RT. Interferon in the treatment of myeloproliferative 
diseases. Semin in Hematol 1990; 27:6-14. 
15. Silver RT. Chronic myeloid leukemia. Hematol /Oncol Clin N 
Amer 1990; 4:319. 
16. Nemunaitis J, Singer JW, Buckner CD, et al . Use of 
recombinant human granulocyte-macrophage colony-stimulating 
factor in autologous marrow transplantation for lymphoid 
malignancies. Blood 1988; 72:834-836. 
17. Ohno R, Tomonaga M, others . Effects of granulocyte 
colony-stimulating factor after intensive induction therapy in 
relapsed or refractory acute leukemia. N E J M 1991; 323:871-877. 
18. Sheridan WP, Morstyn G, Wolf M, others . Granulocyte 
colony-stimulating factor and neutrophil recovery after high-dose 
chemotherapy and autologous bone marrow transplantation. Lancet 
1989; 2:891-895. 
19. Asano S, Masaoka T, Takaku F. Beneficial effect of 
recombinant human glycosylated granulocyte colony-stimulating 
factor in marrow-transplanted patients: results of multicenter 
phase II-III studies. Transplant Proc 1991; 23:1701-1703. 
20. Brandt SJ, Peters WP, Atwater SK, et al. Effect of 
recombinant human granulocyte-macrophage colony-stimulating 
factor on hematopoietic reconstitution after high-dose 
chemotherapy and autologous bone marrow transplantation. N E J M 
1988; 318:869-76. 
21. Deverequx S, Linch DC, Gribben A, McMillan K, Patterson K, 
Goldstone AH. GM-CSF accelerates neutrophil recovery after 
autologous bone marrow transplantation for Hodgkin's disease. 
Bone Marrow Transplant 1991; 34:22-29. 
[176] 
Recombinant DNA Research, Volume 16 
